Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
Akpolat
T
T
Ondokuz Mayis University School of Medicine, Samsun, Turkey.
Arik
N
N
Günaydin
M
M
Utaş
C
C
Dilek
K
K
Caglar
S
S
Candan
F
F
Süleymanlar
G
G
Paydaş
S
S
Sen
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control; D018937:Hepatitis C Antibodies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors; D014421:Turkey / Q000453:epidemiology
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies